Literature DB >> 27681950

[Pitfalls in the histopathological diagnostics of endometrial carcinoma and its precursors : Clinically relevant differential diagnoses, avoidance of false positive diagnoses].

F Kommoss1, S F Lax2.   

Abstract

Making an incorrect histopathological diagnosis of an endometrial lesion may lead to unwanted loss of fertility and therapy-associated morbidity; therefore, endometrial carcinomas need to be correctly typed and differentiated from hyperplastic precursors, benign lesions and artifacts. Typical diagnostic pitfalls are described in this article. Misdiagnosing endometrial lesions can be avoided by paying thorough attention to gross as well as microscopic features and by taking crucial differential diagnoses into consideration. These are, in particular, well-differentiated endometrioid adenocarcinoma of the endometrium versus atypical endometrial hyperplasia, myoinvasive endometrioid adenocarcinoma versus atypical polypoid adenomyoma and endometrioid carcinoma versus serous carcinoma of the endometrium with a predominantly glandular pattern. It is also important to consider the possibility of a false positive diagnosis of atypical endometrial hyperplasia or carcinoma in cases of biopsy-induced artifacts.

Entities:  

Keywords:  Adenomyoma; Diagnostic errors; Endometrial hyperplasia; Endometrioid adenocarcinoma; Hyperplasia

Mesh:

Year:  2016        PMID: 27681950     DOI: 10.1007/s00292-016-0236-y

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  33 in total

1.  Proposed criteria for the diagnosis of well-differentiated endometrial carcinoma. A diagnostic test for myoinvasion.

Authors:  T A Longacre; M H Chung; D N Jensen; M R Hendrickson
Journal:  Am J Surg Pathol       Date:  1995-04       Impact factor: 6.394

Review 2.  A proposed model for endometrial serous carcinogenesis.

Authors:  Wenxin Zheng; Li Xiang; Oluwole Fadare; Beihua Kong
Journal:  Am J Surg Pathol       Date:  2011-01       Impact factor: 6.394

3.  Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation.

Authors:  D T Wheeler; K A Bell; R J Kurman; M E Sherman
Journal:  Am J Surg Pathol       Date:  2000-06       Impact factor: 6.394

Review 4.  The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system.

Authors:  Jan P Baak; George L Mutter; Stanley Robboy; Paul J van Diest; Anne M Uyterlinde; Anne Orbo; Juan Palazzo; Bent Fiane; Kjell Løvslett; Curt Burger; Feja Voorhorst; René H Verheijen
Journal:  Cancer       Date:  2005-06-01       Impact factor: 6.860

5.  Atypical polypoid adenomyofibroma (APA) versus well-differentiated endometrial carcinoma with prominent stromal matrix: an immunohistochemical study.

Authors:  R A Soslow; M H Chung; R V Rouse; M R Hendrickson; T A Longacre
Journal:  Int J Gynecol Pathol       Date:  1996-07       Impact factor: 2.762

6.  Endometrial adenocarcinoma with variable-level myometrial involvement limited to adenomyosis: a clinicopathologic study of 23 cases.

Authors:  S M Jacques; W D Lawrence
Journal:  Gynecol Oncol       Date:  1990-06       Impact factor: 5.482

7.  Diagnosing endometrial hyperplasia: why is it so difficult to agree?

Authors:  Kimberly H Allison; Susan D Reed; Lynda F Voigt; Carolyn D Jordan; Kathryn M Newton; Rochelle L Garcia
Journal:  Am J Surg Pathol       Date:  2008-05       Impact factor: 6.394

8.  Atypical polypoid adenomyoma of the uterus. A report of 27 cases.

Authors:  R H Young; T Treger; R E Scully
Journal:  Am J Clin Pathol       Date:  1986-08       Impact factor: 2.493

9.  The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients.

Authors:  R J Kurman; P F Kaminski; H J Norris
Journal:  Cancer       Date:  1985-07-15       Impact factor: 6.860

10.  Atypical polypoid adenomyomas of the endometrium.

Authors:  M T Mazur
Journal:  Am J Surg Pathol       Date:  1981-07       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.